BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1681
+0.0082 (5.13%)
Oct 13, 2025, 4:00 PM EDT
BioLargo Revenue
BioLargo had revenue of $2.78M in the quarter ending June 30, 2025, a decrease of -44.62%. This brings the company's revenue in the last twelve months to $14.05M, down -16.43% year-over-year. In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth.
Revenue (ttm)
14.05M
Revenue Growth
-16.43%
P/S Ratio
3.53
Revenue / Employee
334.57K
Employees
44
Market Cap
49.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Monarch Cement Company | 252.15M |
| Panamera Holdings | 212.04K |
| Premier Development & Investment | 1.10M |
| Rubber Leaf | 2.02M |
| Cardinal Ethanol, LLC | 350.34M |
| Xtra Energy | 559.33K |
BioLargo News
- 18 hours ago - BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion - Accesswire
- 6 days ago - BioLargo Protects Its Intellectual Property That Built a National Brand - Pooph's License Was Revoked for Non-Payment and Unauthorized Activities - Accesswire
- 14 days ago - BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology - Accesswire
- 17 days ago - BioLargo to Showcase Breakthrough PFAS Solutions at WEFTEC 2025, Booth #6009 - Accesswire
- 18 days ago - BioLargo Protects its Intellectual Property, Revokes Pooph License Due to Failure to Pay and Other Contract Breaches - Accesswire
- 2 months ago - BioLargo Reports Q2 2025 Operating and Financial Results - Accesswire
- 2 months ago - BioLargo Q2 2025 Earnings Results Webcast and Conference Call on Friday, August 15, 2025 - 11 AM Eastern Time - Accesswire
- 2 months ago - BioLargo Provides Review of 2025 Accomplishments and Insights for Coming Year - Accesswire